Myomo (MYO) EPS (Basic) Growth (1y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.42% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.04% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.88% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 95.65% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 8.20% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 92.59% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -30.89% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 51.01% |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -200.00% |
| Jun 30, 2025 | -266.67% |
| Mar 31, 2025 | 20.00% |
| Dec 31, 2024 | 1,313.25% |
| Sep 30, 2024 | 50.00% |
| Jun 30, 2024 | 25.00% |
| Mar 31, 2024 | 9.09% |
| Dec 31, 2023 | 75.00% |
| Sep 30, 2023 | 85.00% |
| Jun 30, 2023 | 90.48% |
| Mar 31, 2023 | 73.17% |
| Dec 31, 2022 | 45.10% |
| Sep 30, 2022 | -11.11% |
| Jun 30, 2022 | 8.70% |
| Mar 31, 2022 | 28.07% |
| Dec 31, 2021 | -1,175.00% |
| Sep 30, 2021 | 48.57% |
| Jun 30, 2021 | 58.93% |
| Mar 31, 2021 | 77.29% |
| Dec 31, 2020 | 99.17% |
| Sep 30, 2020 | 85.63% |
| Jun 30, 2020 | 75.11% |
| Mar 31, 2020 | 63.20% |
| Dec 31, 2019 | 80.46% |
| Sep 30, 2019 | -2,219.05% |
| Jun 30, 2019 | -2,042.86% |
| Mar 31, 2019 | -3,310.00% |
| Dec 31, 2018 | -5,681.82% |
| Sep 30, 2018 | 0.00% |
| Jun 30, 2018 | 93.73% |
| Mar 31, 2018 | 87.10% |
| Dec 31, 2017 | 134.65% |
| Sep 30, 2017 | 80.73% |
| Jun 30, 2017 | -256.38% |